Navigation Links
Renovis Reports Third Quarter 2007 Financial Results
Date:11/6/2007

evelopment efforts.

The inducement stock options cover an aggregate of 20,400 shares of common stock and are classified as non-qualified stock options with an exercise price equal to the fair market value on the date of grant. These options were granted without stockholder approval pursuant to NASDAQ Marketplace Rule 4350 (i)(1)(A)(iv) with the Company's standard stock option terms, including a 10-year term and vesting over fours years.

About Renovis

Renovis is a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammatory diseases. In addition, Renovis has a worldwide collaboration and license agreement with Pfizer to research, develop and commercialize small molecule vanilloid receptor (VR1) antagonists and an agreement with Genentech, Inc. in the areas of nerve growth and anti-angiogenesis.

For additional information about the company, please visit http://www.renovis.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial results, including future revenues and future operating expenses, future preclinical and clinical development, anticipated preclinical and clinical development progress, the anticipated benefits of the business combination transaction involving Evotec and Renovis, the timing of the completion of such transaction and the plans and objectives of management are forward-looking statements and are based on management's current expec
'/>"/>

SOURCE Renovis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Renovis to Present at CIBC World Markets Healthcare Conference
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... has completed the delivery of Brookfield Engineering’s Powder Flow Tester ... enclosure with a smaller footprint and more compact design. ... ... 2009 -- ThermoFab, a US-based thermoforming company, has completed the ... move from sheet metal to a plastic enclosure with a ...
(Date:12/11/2009)... 11 Dendreon Corporation (Nasdaq: DNDN ... previously announced public offering have exercised in full ... of common stock at the public offering price ... the option increases the size of the offering ... stock. Dendreon expects to receive net proceeds ...
(Date:12/11/2009)... have observed the "hot electron" effect in a solar ... elusive charges using ultra-thin solar cells, opening a potential ... in the current online edition of Applied Physics ... cells, it generates free electrons in a range of ... the electrons must reach the bottom of the conduction ...
(Date:12/11/2009)... -- Marrone Bio Innovations (MBI) today announces 2 ... Chris Hildreth joined MBI as Senior Vice President ... all commercial aspects of the company, including sales, ... (Ray) Lam joined MBI as Vice President of ... in scaling its broad pipeline of products to ...
Breaking Biology Technology:Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Elusive 'hot' electrons captured in ultra-thin solar cells 2Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3
... Covance Inc. (NYSE: CVD ) today reported earnings ... per diluted share versus $0.76 per diluted share in the ... excluding the centralized ECG gain on sale). "On a consolidated ... impact of foreign exchange), operating margin was 12.7%, and diluted ...
... April 29 Sangamo BioSciences, Inc. (Nasdaq: ... its zinc finger DNA-binding protein (ZFP) technology. New ... by licensing partner Dow AgroSciences and Sangamo ... the efficient generation of maize plants with multiple, ...
... five-year, $6.7 million Susan G. Komen for the Cure ... Kimmel Cancer Center has partnered with ... analytics and machine learning to uncover life-saving answers hidden ... will leverage its expertise in developing predictive algorithms to ...
Other Biology Technology:Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 2Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 3Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 4Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 5Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 6Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 7Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 8Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 9Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 10Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 11Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 12Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species 2Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species 3Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species 4DecisionQ Partners With Thomas Jefferson University to Reveal Insights for Cancer Therapy 2
(Date:12/15/2009)... near future, consumers can look forward to ultra-low ... laptops, PDAs and mobile phones. This is made ... technologies which are critical elements for power optimisation ... systems. , Analog IC design is the key ... To pre-position the nation in advanced analog and ...
(Date:12/14/2009)... -- (Dec. 14, 2009) -- Researchers at Rice University ... single nanoparticle that can be tracked in real time ... tags them with a fluorescent dye and kills them ... first examples from a growing field called "theranostics" that ... diseases in a single procedure. , The research is ...
(Date:12/14/2009)... The most comprehensive study to date of the ... appendages may provide important clues to how similar regeneration ... the School of Science at Indiana University-Purdue University Indianapolis ... amputated limbs of axolotls, a type of salamander that ... any level of amputation, with the hope that this ...
Breaking Biology News(10 mins):NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Tracking new cancer-killing particles with MRI 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2Einstein receives 242 1 million federal grant to support Hispanic Center of Excellence 58716 1Einstein receives 242 1 million federal grant to support Hispanic Center of Excellence 58716 2Pharmasset to Present at JMP Securities Healthcare Conference 58712 1Pharmasset to Present at JMP Securities Healthcare Conference 58712 2Pharmasset to Present at JMP Securities Healthcare Conference 58712 3More than 5 000 Gallons of Bottled Water Now Available to Atlanta area Residents Coping with the Aftermath of Recent Flooding 58707 1More than 5 000 Gallons of Bottled Water Now Available to Atlanta area Residents Coping with the Aftermath of Recent Flooding 58707 2
... from the University of Exeter in collaboration with the University ... February 2008) questions claims that EU conservation policy has been ... the EU Birds Directive set out a plan to protect ... from the RSPB and BirdLife International, published in Science in ...
... , Mercurys gravity is too weak to hold ... the surface by solar photons or other energetic processes, ... by solar radiation pressure. The neutral components of this ... from the Sun. Baumgardner et al. study this tail ...
... -- The structure and behavior of one of the most ... level of detail never before seen, thanks to new research ... Department of Energys (DOE) Argonne National Laboratory. , Illinois Institute ... by the APS to examine the structure of collagen, a ...
Other Biology News:Exeter scientists pour cold water on EU bird policy 2AGU journal highlights -- Feb. 26, 2008 2AGU journal highlights -- Feb. 26, 2008 3AGU journal highlights -- Feb. 26, 2008 4AGU journal highlights -- Feb. 26, 2008 5AGU journal highlights -- Feb. 26, 2008 6Research at Argonne's Advanced Photon Source reveals structure and behavior of collagen 2
The VersArray hybridization chamber is used for manual (coverslip) hybridization of microarrays. The chamber accommodates 2 slides and is watertight to allow incubation of slides in a water bath. Dim...
... The Eclipse is a state-of-the-art separation ... Fractionation (AFFF) technique. The Eclipse integrates easily ... DAWN, miniDAWN Tristar, as well as the ... size and molar mass distributions of the ...
Monoclonal antibodies conjugated with rhodamine...
... and lightweight, the Moticam 2300 camera (MC2300) ... eyepiece, eyetube, or trinocular port. Included in ... Plug-and-Play Images 2.0ML software offers quick and ... to maximize resolution for examination or documentation ...
Biology Products: